XOLAIR® Pre-filled syringe


Solution for injection in pre-filled syringe
scheduling status
S4
registration number
55/34/0713, 55/34/0714
What XOLAIR® Pre-filled syringe contains
Omalizumab 75 mg/0.5mL Omalizumab 150 mg/mL.
other ingredients
L-arginine hydrochloride, L-histidine hydrochloride, L-histidine, polysorbate 20, water for injection.
Therapeutic classification
R03DX05.
© 2026 SAHPRA. ALL RIGHTS RESERVED